Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 31 tags : Drug save search
Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 2.04%
H: 6.09%
C: 3.97%
treatment drug application submission friedreich’s ataxia
HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery
Published: 2022-03-31 (Crawled : 21:00) - globenewswire.com
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: 3.17%
H: 4.6%
C: -7.26%
drug
Global Human Liver Model Market Research Report to 2027 - Growing Focus on Drug Discovery Activities Presents Opportunities
Published: 2022-03-31 (Crawled : 16:00) - prnewswire.com
TMO | News | $543.03 0.28% 300K
|
Health Technology
|
| O: -0.09%
H: 1.49%
C: -0.28%
drug research liver report growing market
Global Addiction Disorders Drugs Market Research Report to 2027 - Availability of Innovative Drugs in the Form of Pills, Sublingual Films and Implants Presents Opportunities
Published: 2022-03-31 (Crawled : 14:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 4.37%
H: 0.0%
C: -1.86%
PRGO | $30.22 0.94% 140K
|
Health Technology
|
| O: 0.05%
H: 1.73%
C: 0.71%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.34%
H: 0.38%
C: -0.58%
MDT | $79.49 0.38% 1.4M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: 0.0%
PMD | $2.56 420
|
Health Services
|
| O: 0.65%
H: 1.74%
C: -0.65%
ALKS | $23.66 -0.42% 290K
|
Health Technology
|
| O: 0.41%
H: 1.27%
C: -1.39%
research report market drug
R&D Efforts for Alzheimer's Therapies on the Rise with over 120 Drugs in Development
Published: 2022-03-31 (Crawled : 13:20) - prnewswire.com
LGVN | News P 0 d | $1.99 -1.0% 250K
|
|
| O: 39.73%
H: 51.65%
C: 46.96%
MESO | $5.15 0.78% 71K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: -2.09%
DNLI | $16.1 -3.01% 280K
|
Health Technology
|
| O: 4.91%
H: 0.0%
C: -5.35%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.34%
H: 1.24%
C: -3.96%
ALEC | $5.165 1.47% 51K
|
Health Technology
|
| O: 0.48%
H: 1.72%
C: -2.2%
drug therapy alzheimer's alzheimer’s
Outlook Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for ONS-5010 as a Treatment for Wet AMD
Published: 2022-03-31 (Crawled : 12:20) - globenewswire.com
OTLK P | $8.4 1.33% 94K
|
Health Technology
|
| O: 0.0%
H: 1.51%
C: -10.55%
ons-5010 treatment drug application license therapeutics food
CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda
Published: 2022-03-31 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: -0.14%
H: 0.49%
C: -0.62%
biopharma acquisition cardiovascular drug
GHIT Fund Announces New Investments: A Total of 740 Million Yen for Malaria Drugs and Vaccine
Published: 2022-03-31 (Crawled : 03:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.69%
H: 0.0%
C: -1.39%
vaccine drug malaria
Everest Medicines Submits New Drug Application in Hong Kong for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer
Published: 2022-03-31 (Crawled : 01:00) - prnewswire.com
GILD | News | $66.33 0.26% 2.8M
|
Health Technology
|
| O: 0.52%
H: 0.08%
C: -0.87%
drug application cancer breast cancer
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.